# Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP

> **NCT07333859** · PHASE4 · COMPLETED · sponsor: **Ankara City Hospital Bilkent** · enrollment: 120 (actual)

## Conditions studied

- Duodenal Spasm
- ERCP
- Sedation

## Interventions

- **DRUG:** Lidocaine Hydrochloride 2%
- **OTHER:** 0.9 % Normal Saline

## Key facts

- **NCT ID:** NCT07333859
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-02-11
- **Primary completion:** 2026-02-11
- **Final completion:** 2026-03-15
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333859, "Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07333859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*